Ask the Expert: Impulse Control Disorders and Parkinson's (2017)

This webinar, led by behavioural neuroscientist Dr. Catharine Winstanley, delves into the research on impulse control disorders induced by dopamine medications in Parkinson's disease treatment, emphasizing their severe impacts on individuals and support networks. She presents her work on modeling gambling-related disorders in animal models and explores strategies for identifying at-risk individuals and developing alternative medications.

In investigating the relationship between dopamine and decision-making in rats, the talk discusses the use of cognitive tasks to study risk aversion. It reveals that dopamine receptor density predicts risk sensitivity in rats, with a focus on the effects of the dopamine agonist ropinirole on decision-making behavior, particularly in the context of Parkinson's disease.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**